VanEck Pharmaceutical ETF (PPH)
| 78.08 Delayed Data As of Dec 02 |  +0.20 / +0.26%Today’s Change | 66.59 Today|||52-Week Range 84.27 | +1.46% Year-to-Date |
Investment Objective
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS ® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Latest PPH News
No recent news for VanEck Pharmaceutical ETF.
Performance
| 1 month | +8.65% | 3 years | +9.90% | |
| 3 months | +11.47% | 5 years | +8.20% | |
| 1 year | +10.92% | Since inception | +9.52% |
Data through 12/03/2022
Quote Details
| Previous close | $77.88 |
| Open day’s range | 77.29 – 78.08 |
| Net asset value (NAV) | 78.11 (12/02/2022) |
| Daily volume | 5,282 |
| Average volume (3 months) | 159,405 |
Data as of 4:00pm ET, 12/02/2022
Peer Comparisonvs. Health ETFs
| PPH | Category | |
|---|---|---|
| Performance 5-yr return | +8.20% | +5.91% |
| Expense Gross exp ratio | 0.35% | 1.00% |
| Risk 5 year sharpe ratio | 0.45 | 0.45 |
| Net assets | $563.9M | $2.0B |
| Average market cap | $88.9B | $49.7B |
| Average P/E | 18.0 | 23.2 |
| Dividend / Share | -- | 0.27% |
Competitors
| FHLC Fidelity MSCI Health Care Index ETF |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| XLV Health Care Select Sector SPDR® Fund |
Holdings
Top 5 SectorsPortfolio weighting
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
Top 10 HoldingsPortfolio weighting
| JNJ Johnson & Johnson | 9.10% |
| LLY Eli Lilly and Co | 6.05% |
| MRK Merck | 5.65% |
| ABBV AbbVie | 5.55% |
| BMY Bristol-Myers Squibb | 5.47% |
| PFE Pfizer | 5.26% |
| NVO Novo Nordisk | 5.04% |
| NVS Novartis | 4.86% |
| AZN AstraZeneca | 4.77% |
| SNY Sanofi | 4.66% |
